Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7]
1 Division of Family Planning, Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA.
2 Division of Family Planning, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA.
3 Division of Family Planning, Department of Obstetrics and Gynecology, The University of Utah, Salt Lake City, UT.
4 Division of Complex Family Planning, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA.
5 Division of Gynecologic Specialties, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh and Magee-Womens Research Institute, Pittsburgh, PA.